Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Advanced Breast Cancer
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Roche Farma, S.A